Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| KLA Corporation(KLAC) | 178,471 | 166,938 | -11,533 | $53.85M | $32.54M | 18.80% | -$21.31M |
| Bristol-Myers Squibb Company(BMY) | 297,243 | 224,245 | -72,998 | $17.13M | $13.99M | 8.08% | -$3.13M |
| Lam Research Corporation(LRCX) | 35,000 | 30,000 | -5,000 | $15.17M | $9.86M | 5.69% | -$5.31M |
| Biodesix, Inc.(BDSX) | 286,804 | 286,804 | 0 | $6.47M | $8.56M | 4.94% | +$2.09M |
| Corcept Therapeutics Incorporated(CORT) | 57,200 | 55,200 | -2,000 | $4.97M | $6.36M | 3.67% | +$1.39M |
| Ovintiv Inc.(OVV) | 107,500 | 107,500 | 0 | $5.66M | $6.22M | 3.59% | +$555.8K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 373,671 | +373,671 | $0 | $5.62M | 3.24% | +$5.62M |
| Solid Biosciences Inc | 666,196 | 715,955 | +49,759 | $6.66M | $5.18M | 2.99% | -$1.48M |
| Protagonist Therapeutics Inc | 35,018 | 35,000 | -18 | $4.29M | $4.93M | 2.85% | +$638.6K |
| Prothena Corp PlcSHS SHS | 449,019 | 449,019 | 0 | $4.40M | $3.76M | 2.17% | -$633.1K |
| Halozyme Therapeutics, Inc.(HALO) | 33,251 | 33,351 | +100 | $2.60M | $3.68M | 2.13% | +$1.08M |
| Stoke Therapeutics, Inc.(STOK) | 178,110 | 138,000 | -40,110 | $5.83M | $3.59M | 2.07% | -$2.24M |
| Neurocrine Biosciences, Inc.(NBIX) | 27,190 | 25,190 | -2,000 | $4.58M | $3.57M | 2.06% | -$1.01M |
| Acadia Pharmaceuticals Inc | 171,000 | 171,000 | 0 | $4.33M | $3.45M | 1.99% | -$880.6K |
| Intellia Therapeutics, Inc.(NTLA) | 500 | 281,365 | +280,865 | $260.0K | $3.39M | 1.96% | +$3.13M |
| Nektar Therapeutics(NKTR) | 81,000 | 46,000 | -35,000 | $5.65M | $2.79M | 1.61% | -$2.87M |
| Vir Biotechnology, Inc.(VIR) | 220,000 | 226,992 | +6,992 | $2.24M | $2.54M | 1.47% | +$296.0K |
| Zenas BioPharma, Inc.(ZBIO) | 93,601 | 93,380 | -221 | $2.38M | $2.52M | 1.45% | +$142.9K |
| Contineum Therapeutics Inc (Ctnm) P @ 15.0 01/15/2027PUT | 0 | 3,500 | +3,500 | $0 | $2.27M | 1.31% | +$2.27M |
| ABIVAX Société AnonymeADS(ABVX) | 17,000 | 21,000 | +4,000 | $2.27M | $2.08M | 1.20% | -$186.0K |
| Biogen Inc.(BIIB) | 9,000 | 9,000 | 0 | $1.94M | $2.03M | 1.17% | +$88.4K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $2.62M | $2.03M | 1.17% | -$593.8K |
| Definium Therapeutics, Inc.(DFTX) | 20,000 | 52,000 | +32,000 | $940.8K | $1.98M | 1.14% | +$1.04M |
| Cytokinetics, Incorporated(CYTK) | 30,000 | 30,000 | 0 | $2.56M | $1.98M | 1.14% | -$578.4K |
| Celldex Therapeutics, Inc.(CLDX) | 69,900 | 57,200 | -12,700 | $2.60M | $1.85M | 1.07% | -$747.1K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $1.84M | $1.68M | 0.97% | -$159.6K |
| Compass Therapeutics, Inc.(CMPX) | 1,675,000 | 1,575,000 | -100,000 | $3.67M | $1.64M | 0.95% | -$2.03M |
| Xenon Pharmaceuticals Inc.(XENE) | 21,032 | 42,995 | +21,963 | $1.27M | $1.60M | 0.92% | +$329.5K |
| Relmada Therapeutics, Inc.(RLMD) | 408,100 | 408,100 | 0 | $2.82M | $1.54M | 0.89% | -$1.29M |
| Travere Therapeutics, Inc.(TVTX) | 29,000 | 25,000 | -4,000 | $1.65M | $1.47M | 0.85% | -$175.5K |
| Adagene IncADS | 240,000 | 430,000 | +190,000 | $1.01M | $1.38M | 0.79% | +$368.0K |
| United Therapeutics Corporation(UTHR) | 4,506 | 2,500 | -2,006 | $2.44M | $1.35M | 0.78% | -$1.09M |
| Freeport-McMoRan Inc.CL B(FCX) | 18,035 | 18,027 | -8 | $1.13M | $1.26M | 0.73% | +$127.7K |
| Quince Therapeutics Inc | 0 | 40,601 | +40,601 | $0 | $1.26M | 0.73% | +$1.26M |
| Valneva SEADS(VALN) | 0 | 201,390 | +201,390 | $0 | $1.25M | 0.72% | +$1.25M |
| BridgeBio Pharma, Inc.(BBIO) | 8,741 | 18,741 | +10,000 | $651.0K | $1.23M | 0.71% | +$582.1K |
| Immunome, Inc.(IMNM) | 50,000 | 55,600 | +5,600 | $1.06M | $1.20M | 0.69% | +$136.5K |
| Axsome Therapeutics, Inc.(AXSM) | 6,000 | 6,000 | 0 | $1.47M | $1.11M | 0.64% | -$362.3K |
| Annexon, Inc.PUT(ANNX) | 0 | 4,370 | +4,370 | $0 | $1.05M | 0.61% | +$1.05M |
| Jatt Ii Acquisition Corp | 0 | 90,455 | +90,455 | $0 | $1.02M | 0.59% | +$1.02M |
| Foghorn Therapeutics Inc.(FHTX) | 281,937 | 282,307 | +370 | $1.38M | $1.01M | 0.58% | -$368.0K |
| Pharvaris N V COM | 29,847 | 29,847 | 0 | $1.03M | $946.7K | 0.55% | -$85.4K |
| Quidelortho Corp | 89,377 | 89,377 | 0 | $1.57M | $942.0K | 0.54% | -$623.4K |
| Blossomhill Therapeutics Inc | 0 | 50,000 | +50,000 | $0 | $932.0K | 0.54% | +$932.0K |
| Disc Medicine, Inc.PUT(IRON) | 0 | 450 | +450 | $0 | $841.5K | 0.49% | +$841.5K |
| Castle Biosciences, Inc.(CSTL) | 12,984 | 22,935 | +9,951 | $309.7K | $814.9K | 0.47% | +$505.2K |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 15,400 | +15,400 | $0 | $767.2K | 0.44% | +$767.2K |
| Harrow, Inc.(HROW) | 24,000 | 24,000 | 0 | $1.02M | $739.2K | 0.43% | -$280.1K |
| Bicycle Therapeutics PlcADS | 313,616 | 176,432 | -137,184 | $1.33M | $649.3K | 0.38% | -$680.5K |
| Voyager Therapeutics, Inc.(VYGR) | 75,147 | 224,918 | +149,771 | $263.0K | $602.8K | 0.35% | +$339.8K |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 0 | 7,600 | +7,600 | $0 | $564.5K | 0.33% | +$564.5K |
| Olema Oncology, Inc.(OLMA) | 199,000 | 59,000 | -140,000 | $2.49M | $509.8K | 0.29% | -$1.98M |
| CorMedix Inc.(CRMD) | 0 | 65,874 | +65,874 | $0 | $507.2K | 0.29% | +$507.2K |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 120,000 | 120,000 | 0 | $524.4K | $484.8K | 0.28% | -$39.6K |
| Abeona Therapeutics Inc.(ABEO) | 0 | 90,700 | +90,700 | $0 | $476.2K | 0.28% | +$476.2K |
| Altimmune, Inc.(ALT) | 152,681 | 160,964 | +8,283 | $464.1K | $460.4K | 0.27% | -$3.8K |
| Vor Biopharma Inc.(VOR) | 0 | 24,000 | +24,000 | $0 | $457.9K | 0.26% | +$457.9K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 36,220 | +36,220 | $0 | $423.8K | 0.24% | +$423.8K |
| Aethlon Medical Inc | 0 | 62,837 | +62,837 | $0 | $409.7K | 0.24% | +$409.7K |
| Pulmonx Corporation(LUNG) | 200,543 | 200,000 | -543 | $260.7K | $382.0K | 0.22% | +$121.3K |
| Pacific Biosciences of California, Inc.(PACB) | 1,350,000 | 160,000 | -1,190,000 | $2.27M | $379.2K | 0.22% | -$1.89M |
| Trinity Capital Inc.(TRIN) | 20,000 | 20,000 | 0 | $357.8K | $351.0K | 0.20% | -$6.8K |
| Silence Therapeutics plcADS(SLN) | 71,218 | 30,000 | -41,218 | $782.0K | $327.9K | 0.19% | -$454.1K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $364.2K | $307.0K | 0.18% | -$57.2K |
| Kayne Anderson BDC, Inc.(KBDC) | 20,000 | 20,000 | 0 | $270.6K | $251.2K | 0.15% | -$19.4K |
| Rezolute, Inc.(RZLT) | 0 | 60,296 | +60,296 | $0 | $249.6K | 0.14% | +$249.6K |
| Entrada Therapeutics, Inc.(TRDA) | 0 | 36,849 | +36,849 | $0 | $234.0K | 0.14% | +$234.0K |
| Immunic, Inc.(IMUX) | 0 | 21,917 | +21,917 | $0 | $203.8K | 0.12% | +$203.8K |
| Cardiol Therapeutics Inc.CL A(CRDL) | 0 | 100,000 | +100,000 | $0 | $166.0K | 0.10% | +$166.0K |
| Ocular Therapeutix, Inc.(OCUL) | 20,655 | 20,450 | -205 | $202.8K | $156.9K | 0.09% | -$46.0K |
| Kazia Therapeutics LtdADS | 0 | 16,000 | +16,000 | $0 | $153.5K | 0.09% | +$153.5K |
| Kyntra Bio, Inc.(KYNB) | 22,566 | 22,566 | 0 | $170.4K | $150.1K | 0.09% | -$20.3K |
| Elutia Inc.(ELUT) | 165,094 | 165,094 | 0 | $161.7K | $130.4K | 0.08% | -$31.3K |
| Biomea Fusion, Inc.(BMEA) | 0 | 93,500 | +93,500 | $0 | $124.4K | 0.07% | +$124.4K |
| Fractyl Health, Inc.(GUTS) | 0 | 165,478 | +165,478 | $0 | $90.1K | 0.05% | +$90.1K |
| Invivyd, Inc.(IVVD) | 342,275 | 75,975 | -266,300 | $298.6K | $66.1K | 0.04% | -$232.5K |
| Lipocine Inc.(LPCN) | 16,712 | 16,712 | 0 | $42.8K | $36.8K | 0.02% | -$6.0K |
| DocGo Inc.(DCGO) | 39,062 | 39,062 | 0 | $20.2K | $15.6K | 0.01% | -$4.5K |
| Bristol Myers Squibb Co RtsRIGHT 12 30 2030 | 0 | 98,527 | +98,527 | $0 | $12.3K | 0.01% | +$12.3K |
| 4d Molecular Therapeutics Inc | 48,505 | 0 | -48,505 | $645.1K | $0 | — | -$645.1K |
| BioAge Labs, Inc.(BIOA) | 69,000 | 0 | -69,000 | $1.69M | $0 | — | -$1.69M |
| Candel Therapeutics, Inc.(CADL) | 47,756 | 0 | -47,756 | $491.9K | $0 | — | -$491.9K |
| Capricor Therapeutics, Inc.(CAPR) | 14,352 | 0 | -14,352 | $345.6K | $0 | — | -$345.6K |
| COMPASS Pathways plcADS(CMPS) | 30,000 | 0 | -30,000 | $424.5K | $0 | — | -$424.5K |
| Gossamer Bio, Inc.(GOSS) | 18,176 | 0 | -18,176 | $3.0K | $0 | — | -$3.0K |
| Grace Therapeutics, Inc.(GRCE) | 120,000 | 0 | -120,000 | $272.4K | $0 | — | -$272.4K |
| Karyopharm Therapeutics Inc.(KPTI) | 42,952 | 0 | -42,952 | $419.6K | $0 | — | -$419.6K |
| Novo Nordisk A/SADR(NVO) | 24,000 | 0 | -24,000 | $1.15M | $0 | — | -$1.15M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 55,000 | 0 | -55,000 | $596.8K | $0 | — | -$596.8K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 20,000 | 0 | -20,000 | $96.8K | $0 | — | -$96.8K |
| Savara Inc.(SVRA) | 80,000 | 0 | -80,000 | $492.8K | $0 | — | -$492.8K |
| Structure Therapeutics IncADR | 24,000 | 0 | -24,000 | $1.29M | $0 | — | -$1.29M |
| uniQure N.V.SHS(QURE) | 50,697 | 0 | -50,697 | $2.34M | $0 | — | -$2.34M |
| UroGen Pharma Ltd.(URGN) | 16,487 | 0 | -16,487 | $606.7K | $0 | — | -$606.7K |
| Vera Therapeutics, Inc.CL A(VERA) | 57,758 | 0 | -57,758 | $2.48M | $0 | — | -$2.48M |